Hypothalamus & PituitaryMay 10, 20265 min read

Everything You Need to Know About Diabetes insipidus (central vs nephrogenic) for Step 1

Deep dive: definition, pathophysiology, clinical presentation, diagnosis, treatment, HY associations for Diabetes insipidus (central vs nephrogenic). Include First Aid cross-references.

Diabetes insipidus (DI) is one of those Step 1 endocrine topics that seems “simple” until a question stem starts throwing around urine osmolality, water deprivation testing, and desmopressin response. The good news: if you can anchor DI to ADH physiology and a clean diagnostic algorithm, you’ll pick up easy points—especially on questions that try to confuse DI with primary polydipsia or osmotic diuresis (diabetes mellitus).


Big Picture: What Is Diabetes Insipidus?

Diabetes insipidus = inability to concentrate urine due to problems with ADH signaling.
Result: excretion of large volumes of dilute urinepolydipsia and risk of hypernatremia if water access is impaired.

Two Major Types (Know the Core Split)

TypeProblemADH levelKidney response to desmopressin (DDAVP)
Central DIDecreased ADH production/release (hypothalamus/posterior pituitary)LowImproves (urine concentrates)
Nephrogenic DIDecreased renal response to ADH (collecting duct)High/normalNo meaningful improvement

First Aid cross-reference: Endocrine → Posterior pituitary (ADH) disorders; DI vs SIADH comparison tables (varies slightly by edition, typically in Pituitary section).


ADH Physiology Refresher (Posterior Pituitary = Storage/Release)

ADH (vasopressin) is made in the hypothalamus (supraoptic and paraventricular nuclei) and released from the posterior pituitary.

Mechanism (Must-Know Receptor + Second Messenger)

  • ADH binds V2 receptors on principal cells in the collecting duct
  • V2 is Gs → ↑cAMP
  • Leads to insertion of aquaporin-2 channels into the apical membrane
  • Water reabsorbed → urine becomes more concentrated

What Stimulates ADH Release?

  • ↑ plasma osmolality (most sensitive)
  • ↓ effective circulating volume/pressure (baroreceptors)

Pathophysiology: Central vs Nephrogenic DI

Central DI: “No ADH”

Mechanism: insufficient ADH → collecting ducts can’t insert aquaporin-2 → water loss.

Classic etiologies (Step 1 favorites):

  • Head trauma (including neurosurgery)
  • Pituitary/hypothalamic tumors
  • Infiltrative disease (e.g., sarcoidosis, Langerhans cell histiocytosis)
  • Autoimmune (idiopathic central DI also tested)
  • Genetic (rare)

High-yield association: Post-op or post-trauma patient with abrupt polyuria and rising sodium.


Nephrogenic DI: “ADH Resistance”

Mechanism: ADH present, but kidney can’t respond → no aquaporin-2 insertion.

Classic etiologies:

  • Lithium (biggest board favorite)
  • Demeclocycline (also causes ADH resistance)
  • Hypercalcemia (impairs concentrating ability)
  • Hypokalemia
  • Chronic kidney disease / tubulointerstitial disease
  • Inherited defects
    • V2 receptor mutation (X-linked)
    • Aquaporin-2 mutation (less common)

High-yield association: Bipolar patient on lithium with polyuria and polydipsia.


Clinical Presentation: How DI Shows Up in Question Stems

Symptoms

  • Polyuria (often >3 L/day; can be massive)
  • Polydipsia
  • Nocturia
  • Preference for cold water sometimes described
  • If unable to drink: dehydration, hypernatremia, neurologic symptoms (confusion, seizures)

Signs/Labs You Should Predict

  • Dilute urine: low urine osmolality and low specific gravity
  • Serum hyperosmolality and often hypernatremia (especially if water intake limited)

Core Lab Pattern Table (Memorize)

ConditionSerum Na+Serum osmolalityUrine osmolalityUrine volume
Central DI↑↑
Nephrogenic DI↑↑
Primary polydipsia↓/N↓/N
Osmotic diuresis (DM)↑/N↑ (glucose pulls water)

Board trap: Not all “polyuria” is DI—diabetes mellitus causes osmotic diuresis with higher urine osmolality (glucose/ketones).


Diagnosis: The Step 1 Algorithm (Water Deprivation + Desmopressin)

Step 0: Confirm Polyuria Is Water Diuresis

  • Check serum glucose, BUN/Cr, calcium, potassium
  • Check urine osmolality (DI = inappropriately low)

Step 1: Water Deprivation Test (Deprivation increases endogenous ADH)

  • Normal physiology: urine osmolality rises with dehydration
  • DI: urine stays dilute despite dehydration (can’t concentrate)

Step 2: Desmopressin (DDAVP) Challenge (Exogenous ADH analog)

  • Central DI: urine osmolality increases significantly
  • Nephrogenic DI: little or no change

Quick Reference (What the question really asks)

Test stepCentral DINephrogenic DI
Water deprivationUrine remains diluteUrine remains dilute
After DDAVPConcentratesNo response

High-yield nuance: Many resources describe “>50% increase in urine osmolality” after DDAVP as strongly suggestive of central DI, while nephrogenic shows minimal change.


Treatment: Know What Fixes What (And the Counterintuitive Thiazide Trick)

Central DI Treatment

  • Desmopressin (DDAVP) is first-line
    • ADH analog with strong V2 activity (less V1 vasoconstriction)
  • Address underlying cause (tumor, trauma, infiltrative disease)

Adverse effect to remember: Hyponatremia/water intoxication if overtreated.


Nephrogenic DI Treatment

  • Stop offending agent (especially lithium)
  • Thiazide diuretics (counterintuitive but very testable)
  • NSAIDs (e.g., indomethacin) can help
  • Amiloride is especially useful for lithium-induced DI

Why do thiazides help DI?

They cause mild volume depletion → increased proximal tubular Na+/water reabsorption → less water delivered to collecting duct → decreased urine volume.

Why NSAIDs help?

Prostaglandins antagonize ADH action in the kidney; NSAIDs reduce prostaglandins → enhance concentrating ability.

First Aid cross-reference: DI treatment pearls often appear alongside renal pharm (thiazides/NSAIDs) and endocrine posterior pituitary section.


HY Associations & Classic Vignettes (What to Recognize Fast)

Central DI Vignettes

  • Post pituitary surgery or head trauma → sudden polyuria, hypernatremia
  • “Infiltrative disease” clues: sarcoidosis, LCH, TB, metastases
  • Low ADH state → responds to DDAVP

Nephrogenic DI Vignettes

  • Lithium therapy history (bipolar disorder)
  • Electrolyte clues: hypercalcemia (stones, bones, groans) or hypokalemia
  • High ADH but resistance → no DDAVP response

Differentiating From Primary Polydipsia (Common Trap)

  • Psychiatric history, compulsive water drinking
  • Low/normal serum sodium and osmolality
  • During water deprivation, urine can usually concentrate at least somewhat, unlike true DI

Rapid-Fire Step 1 “If You See X, Think Y”

  • Polyuria + hypernatremia + low urine osmolality → DI until proven otherwise
  • DI + improves with DDAVPcentral
  • DI + lithiumnephrogenic
  • Nephrogenic DI treatment includes thiazides (paradox) and amiloride (lithium)
  • ADH works via V2 (Gs → cAMP) → aquaporin-2 insertion

Mini Self-Check (1-minute Quiz)

  1. Patient with polyuria after head trauma has urine osmolality 80 mOsm/kg. After DDAVP, urine osmolality rises to 500. Diagnosis?
  • Central DI
  1. Bipolar patient on lithium: water deprivation doesn’t concentrate urine; DDAVP doesn’t help. Best targeted medication?
  • Amiloride (plus consider thiazide/NSAID strategies and stopping lithium)
  1. Why do thiazides reduce urine volume in nephrogenic DI?
  • Increase proximal reabsorption via mild volume depletion → less water reaches collecting duct

Key Takeaways (What to Memorize)

  • Central DI = low ADH; Nephrogenic DI = ADH resistance
  • Both cause polyuria + dilute urine; distinguish with DDAVP response
  • Lithium is a top cause of nephrogenic DI; treat with amiloride and/or thiazides
  • Water deprivation test + DDAVP is the classic diagnostic pathway